261 related articles for article (PubMed ID: 26691308)
1. Vitamin D improves diabetic nephropathy in rats by inhibiting renin and relieving oxidative stress.
Deng X; Cheng J; Shen M
J Endocrinol Invest; 2016 Jun; 39(6):657-66. PubMed ID: 26691308
[TBL] [Abstract][Full Text] [Related]
2. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
Zhang Z; Zhang Y; Ning G; Deb DK; Kong J; Li YC
Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15896-901. PubMed ID: 18838678
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
[TBL] [Abstract][Full Text] [Related]
4. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
Ge J; Miao JJ; Sun XY; Yu JY
J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
[TBL] [Abstract][Full Text] [Related]
5. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
[TBL] [Abstract][Full Text] [Related]
6. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
Anjaneyulu M; Chopra K
Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D protects against diabetic nephropathy: Evidence-based effectiveness and mechanism.
Hu X; Liu W; Yan Y; Liu H; Huang Q; Xiao Y; Gong Z; Du J
Eur J Pharmacol; 2019 Feb; 845():91-98. PubMed ID: 30287151
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D protection from rat diabetic nephropathy is partly mediated through Klotho expression and renin-angiotensin inhibition.
Eltablawy N; Ashour H; Rashed LA; Hamza WM
Arch Physiol Biochem; 2018 Dec; 124(5):461-467. PubMed ID: 29308676
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
Tamura J; Konno A; Hashimoto Y; Kon Y
Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
[TBL] [Abstract][Full Text] [Related]
10. Effect of combination therapy with angiotensin receptor blocker and 1,25-dihydroxyvitamin D(3) in type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Ohara I; Tanimoto M; Gohda T; Yamazaki T; Hagiwara S; Murakoshi M; Aoki T; Toyoda H; Ishikawa Y; Funabiki K; Horikoshi S; Tomino Y
Nephron Exp Nephrol; 2011; 117(4):e124-32. PubMed ID: 20948237
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and diabetic nephropathy.
Li YC
Curr Diab Rep; 2008 Dec; 8(6):464-9. PubMed ID: 18990303
[TBL] [Abstract][Full Text] [Related]
12. [Effects of irbesartan on renal advanced glycation end products and their receptor in rats with early diabetic nephropathy].
Long HB; Niu HX; Li XY; Zhou WD; He JH; Zhong J; Wei LB
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2433-6, 2441. PubMed ID: 20034895
[TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
[TBL] [Abstract][Full Text] [Related]
14. Effects of paricalcitol and aliskiren combination therapy on experimental diabetic nephropathy model in rats.
Eren Z; Günal MY; Bakir EA; Coban J; Çağlayan B; Ekimci N; Ethemoglu S; Albayrak O; Akdeniz T; Demirel GY; Kiliç E; Kantarci G
Kidney Blood Press Res; 2014; 39(6):581-90. PubMed ID: 25532067
[TBL] [Abstract][Full Text] [Related]
15. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
[TBL] [Abstract][Full Text] [Related]
16. Huangkui capsule attenuates renal fibrosis in diabetic nephropathy rats through regulating oxidative stress and p38MAPK/Akt pathways, compared to α-lipoic acid.
Mao ZM; Shen SM; Wan YG; Sun W; Chen HL; Huang MM; Yang JJ; Wu W; Tang HT; Tang RM
J Ethnopharmacol; 2015 Sep; 173():256-65. PubMed ID: 26226437
[TBL] [Abstract][Full Text] [Related]
17. Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome.
Luo ZF; Qi W; Feng B; Mu J; Zeng W; Guo YH; Pang Q; Ye ZL; Liu L; Yuan FH
Life Sci; 2011 Mar; 88(11-12):512-20. PubMed ID: 21241714
[TBL] [Abstract][Full Text] [Related]
18. [Effects and mechanisms of huangkui capsule ameliorating renal fibrosis in diabetic nephropathy rats via inhibiting oxidative stress and p38MAPK signaling pathway activity in kidney].
Mao ZM; Wan YG; Sun W; Chen HL; Huang YR; Shi XM; Yao J
Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(21):4110-7. PubMed ID: 25775777
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D activates the Nrf2-Keap1 antioxidant pathway and ameliorates nephropathy in diabetic rats.
Nakai K; Fujii H; Kono K; Goto S; Kitazawa R; Kitazawa S; Hirata M; Shinohara M; Fukagawa M; Nishi S
Am J Hypertens; 2014 Apr; 27(4):586-95. PubMed ID: 24025724
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of glyoxalase 1 by mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats.
Liu YW; Zhu X; Zhang L; Lu Q; Wang JY; Zhang F; Guo H; Yin JL; Yin XX
Eur J Pharmacol; 2013 Dec; 721(1-3):355-64. PubMed ID: 24036348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
